Report Detail
Global Hepatitis A Vaccine Market Growth 2019-2024
- RnM3072112 |
- 07 March, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Food & Beverages
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.
Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
According to this study, over the next five years the Hepatitis A Vaccine market will register a 2.8% CAGR in terms of revenue, the global market size will reach US$ 770 million by 2024, from US$ 650 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hepatitis A Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A Vaccine market by product type, application, key manufacturers and key regions and countries.
This study considers the Hepatitis A Vaccine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Inactivated Vaccine
Live Attenuated Vaccine
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Government Institution
Private Sector
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hepatitis A Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hepatitis A Vaccine market by identifying its various subsegments.
Focuses on the key global Hepatitis A Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hepatitis A Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hepatitis A Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Hepatitis A Vaccine Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Hepatitis A Vaccine Consumption 2014-2024
- 2.1.2 Hepatitis A Vaccine Consumption CAGR by Region
- 2.2 Hepatitis A Vaccine Segment by Type
- 2.2.1 Inactivated Vaccine
- 2.2.2 Live Attenuated Vaccine
- 2.3 Hepatitis A Vaccine Consumption by Type
- 2.3.1 Global Hepatitis A Vaccine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Hepatitis A Vaccine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Hepatitis A Vaccine Sale Price by Type (2014-2019)
- 2.4 Hepatitis A Vaccine Segment by Application
- 2.4.1 Government Institution
- 2.4.2 Private Sector
- 2.4.3 Other
- 2.5 Hepatitis A Vaccine Consumption by Application
- 2.5.1 Global Hepatitis A Vaccine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Hepatitis A Vaccine Value and Market Share by Application (2014-2019)
- 2.5.3 Global Hepatitis A Vaccine Sale Price by Application (2014-2019)
3 Global Hepatitis A Vaccine by Players
- 3.1 Global Hepatitis A Vaccine Sales Market Share by Players
- 3.1.1 Global Hepatitis A Vaccine Sales by Players (2017-2019)
- 3.1.2 Global Hepatitis A Vaccine Sales Market Share by Players (2017-2019)
- 3.2 Global Hepatitis A Vaccine Revenue Market Share by Players
- 3.2.1 Global Hepatitis A Vaccine Revenue by Players (2017-2019)
- 3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Players (2017-2019)
- 3.3 Global Hepatitis A Vaccine Sale Price by Players
- 3.4 Global Hepatitis A Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Hepatitis A Vaccine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Hepatitis A Vaccine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Hepatitis A Vaccine by Regions
- 4.1 Hepatitis A Vaccine by Regions
- 4.1.1 Global Hepatitis A Vaccine Consumption by Regions
- 4.1.2 Global Hepatitis A Vaccine Value by Regions
- 4.2 Americas Hepatitis A Vaccine Consumption Growth
- 4.3 APAC Hepatitis A Vaccine Consumption Growth
- 4.4 Europe Hepatitis A Vaccine Consumption Growth
- 4.5 Middle East & Africa Hepatitis A Vaccine Consumption Growth
5 Americas
- 5.1 Americas Hepatitis A Vaccine Consumption by Countries
- 5.1.1 Americas Hepatitis A Vaccine Consumption by Countries (2014-2019)
- 5.1.2 Americas Hepatitis A Vaccine Value by Countries (2014-2019)
- 5.2 Americas Hepatitis A Vaccine Consumption by Type
- 5.3 Americas Hepatitis A Vaccine Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Hepatitis A Vaccine Consumption by Countries
- 6.1.1 APAC Hepatitis A Vaccine Consumption by Countries (2014-2019)
- 6.1.2 APAC Hepatitis A Vaccine Value by Countries (2014-2019)
- 6.2 APAC Hepatitis A Vaccine Consumption by Type
- 6.3 APAC Hepatitis A Vaccine Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Hepatitis A Vaccine by Countries
- 7.1.1 Europe Hepatitis A Vaccine Consumption by Countries (2014-2019)
- 7.1.2 Europe Hepatitis A Vaccine Value by Countries (2014-2019)
- 7.2 Europe Hepatitis A Vaccine Consumption by Type
- 7.3 Europe Hepatitis A Vaccine Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Hepatitis A Vaccine by Countries
- 8.1.1 Middle East & Africa Hepatitis A Vaccine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Hepatitis A Vaccine Value by Countries (2014-2019)
- 8.2 Middle East & Africa Hepatitis A Vaccine Consumption by Type
- 8.3 Middle East & Africa Hepatitis A Vaccine Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Hepatitis A Vaccine Distributors
- 10.3 Hepatitis A Vaccine Customer
11 Global Hepatitis A Vaccine Market Forecast
- 11.1 Global Hepatitis A Vaccine Consumption Forecast (2019-2024)
- 11.2 Global Hepatitis A Vaccine Forecast by Regions
- 11.2.1 Global Hepatitis A Vaccine Forecast by Regions (2019-2024)
- 11.2.2 Global Hepatitis A Vaccine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Hepatitis A Vaccine Forecast by Type
- 11.8 Global Hepatitis A Vaccine Forecast by Application
12 Key Players Analysis
- 12.1 GSK
- 12.1.1 Company Details
- 12.1.2 Hepatitis A Vaccine Product Offered
- 12.1.3 GSK Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 GSK News
- 12.2 Merck
- 12.2.1 Company Details
- 12.2.2 Hepatitis A Vaccine Product Offered
- 12.2.3 Merck Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Merck News
- 12.3 Sanofi
- 12.3.1 Company Details
- 12.3.2 Hepatitis A Vaccine Product Offered
- 12.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Sanofi News
- 12.4 Sinovac
- 12.4.1 Company Details
- 12.4.2 Hepatitis A Vaccine Product Offered
- 12.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sinovac News
- 12.5 Zhejiang Pukang
- 12.5.1 Company Details
- 12.5.2 Hepatitis A Vaccine Product Offered
- 12.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Zhejiang Pukang News
- 12.6 Changchun Institute of Biological
- 12.6.1 Company Details
- 12.6.2 Hepatitis A Vaccine Product Offered
- 12.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Changchun Institute of Biological News
- 12.7 Kaketsuken
- 12.7.1 Company Details
- 12.7.2 Hepatitis A Vaccine Product Offered
- 12.7.3 Kaketsuken Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Kaketsuken News
- 12.8 IMBCA
- 12.8.1 Company Details
- 12.8.2 Hepatitis A Vaccine Product Offered
- 12.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 IMBCA News
- 12.9 ChangSheng
- 12.9.1 Company Details
- 12.9.2 Hepatitis A Vaccine Product Offered
- 12.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 ChangSheng News
- 12.10 Convac
- 12.10.1 Company Details
- 12.10.2 Hepatitis A Vaccine Product Offered
- 12.10.3 Convac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Convac News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Hepatitis A Vaccine. Industry analysis & Market Report on Hepatitis A Vaccine is a syndicated market report, published as Global Hepatitis A Vaccine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Hepatitis A Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
